Abstract:

Abstract Introduction: Pharmacies, within the scope of the Unified Health System (SUS), must comply with health standards, as well as follow the guidelines established by the Ministry of Health to guarantee access to safe, effective and quality medicines. Objective: To characterize the technical issues and conservation conditions of medicines of primary care in the Unified Health System, in the capitals of Brazil, grouped by regions, about technical-sanitary requirements, storage and environmental conditions, fire safety and electrical breakdown items, control system of inventory, fractionation, waste management, regulation of advertising/promotion of medicines, actions related to pharmacovigilance and transport. Method: Cross-sectional, exploratory study, covering 455 pharmacies in primary care services in the capitals of Brazil, which constitute a subsample of the Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM). An observation guide and interviews were used with those responsible for pharmaceutical assistance (n = 24) and those responsible for delivering medicines to services (n = 108). Results: Non-compliance with technical and sanitary conditions, which can interfere in maintaining stability, quality, efficacy, and safety, indicating management problems, infrastructure and quality of pharmaceutical services were identified, in addition to possible increased costs for the system due to losses. More deficient sanitary conditions in general were found in the capitals of the North and Northeast and better conditions in the capitals of other regions. Conclusions: Pharmacies of the SUS primary health network face problems in management, infrastructure, organization, and quality of pharmaceutical services that can compromise the quality of the medicines offered, and increase costs for the system. Improvement of management, investments in infrastructure and in the qualification of human resources, and improvement of inspection and health surveillance are urgently needed for essential medicines and pharmaceutical assistance policies to be effective.

Keywords: